News | December 24, 2021
Indian Pharmaceutical Market grew at 6.6 pc in November
Flattish volume growth and subdued new launches were key factors for last month
Flattish volume growth and subdued new launches were key factors for last month
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
Autism spectrum disorder affects 78 million people and families worldwide
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research
The data has been shared with the U.S.FDA as part of an ongoing rolling submission for Emergency Use Authorisation
Subscribe To Our Newsletter & Stay Updated
